ARCHIVES

Combined analysis moves Herceptin to adjuvant setting in breast cancer.

This article is from The Cancer Letter archive.

Vol. 31 No. 21 | May 27, 2005

Download PDF Visit The Full Archive

Related Articles

Boyd’s Rebuttal to DePinho’s Letter to the AAUP

May 30, 2014

House Appropriators Approve NIH Increase; Clinton Threatens Veto Over Education Cuts

July 17, 1998

Finasteride Cut Risk Of Prostate Cancer In Large Trial, But Value In Clinic Unclear.

June 27, 2003

National Cancer Act: Early Promises Were Overstated

May 15, 1998

DES Study Indicates Threat If Vaginal Cancer May Not Be Serious

November 15, 1974

Researchers Find Two Types Of MCL Drug Resistance

August 29, 2014